Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis

Purpose of investigation: Endometriosis is a common finding in women with infertility, but the mechanism by which it renders a woman infertile remains unclear. The medical treatment of pelvic endometriosis includes hormonal therapy that directly attacks endometriosis lesions or indirectly by inhibiting endometrial proliferation through estrogenic deprivation. The aim of this study was to compare the efficacy and safety of leuprorelin acetate depot and danazol for endometriosis in infertile women.

Methods: This randomized trial involved 81 women 19-41 years old with regular menses and known pelvic endometriosis who were recruited from the Fertility Center of the Second University of Naples between 1992 and 1999. Fifty-four women were given 3.75 mg of leuprolide acetate depot every 28 days for 24 weeks and the remaining 27 took 200 mg of danazol three times daily for 24 weeks. Efficacy assessments were based on pre-admission and end-of-treatment laparoscopic scores and subjective symptoms scores at 4-week intervals during and after treatment. Safety was evaluated by adverse events and clinical laboratory tests.

Results: In each group, endometriosis growth and symptoms significantly improved during treatment (p < 0.001). Significantly fewer patients randomized to leuprorelin acetate (5.5%) withdrew during treatment compared with 18.5% randomized to danazol (p < 0.05). After treatment symptoms returned in each group, but severity was less than at admission at all time points (p < 0.02). Hypoestrogenic side-effects were more common in those receiving leuprorelin, particularly hot flushes, but anabolic/androgenic side-effects of weight gain and acne were more common in those receiving danazol.

Conclusion: Both leuprorelin acetate depot and danazol are effective in the treatment of endometriosis in infertile patients. The hypoestrogenic side-effects of leuprorelin may be better tolerated than the androgenic, anabolic effects of danazol.

Endometriosis; Danazol; Leuprorelin acetate depot; Gonadotropin-releasing hormone analogues; Infertility

[1] Soules M. R., Malinak L. R., Bury R. and Poindexter A.: "Endometriosis and anovulation: a coexisting problem in the infertile female". Am. J. Obstet. Gyneco/., 1976, 125, 412.

[2] Wallace A. M., Lees D. A., Roberts A. D., Grayce A., McLaren E H., Low R. A.: "Danazol and prolactin status in patients with endometriosis". Acta Endocrinol., 1984, 107, 445.

[3] Badawi S. Z., Marshall L., Cuenca, V.: "Peritoneal fluid prostaglandins in various stages of the menstrual cycle: role in infertile patients with endometriosis". Int. J. Fertil., 1985, 30, 48.

[4] Ylikorkala 0., Koskimies A., Laatkainen T., Tenhunen A, Viinikka L.: "Peritoneal fluid prostaglandin、in endometriosis, tubal disorders and unexplained infertility". Obstet. Gynecol., 1984, 63, 616.

[5] Lessey B. A.: "Medical management of endometriosis and infertility". Fertil. Steril., 2000, 73, 1089.

[6] Shaw R. W.: "Treatment of endometriosis". Lancet, l 992, 340, 1267.

[7] Dmowski W. P., Headley S., Radwanska E.: "Effects of danazol on pulsatile gonadotrophin patterns and on serum estradiol levels in normally cycling women". Fertil. Steril., 1983, 39, 49.

[8] Sandow J.: "Clinical applications of LHRH and its analogues" Clin. Endocrinol., 1983, 18, 571.

[9] Bergquist C., Nillius S. J., Wide L.: "Intranasal LHRH agonist treatment for inhibition of ovulation in women: clinical aspects". Clin. Endocrinol., 1982, 17, 91.

[10] Chang S. P., Ng H. T.: "A randomized comparative study of the effect of leuprorelin acetate depot and danazol in the treatment of endometrriosis". Chung Hua I Hsueh Tsa Chih, 1996, 57, 431.

[11] Dawood M. Y., Ramos J., Khan-Dawood, F. S.: "Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin". Fertil. Steril., 1995, 63, 1177.

[12] Palagiano A., Capuano V.: "Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol". Minerva Ginecol., 1994, 46, 173.

[13] Wheeler J. M., Knittle J. D., Miller J. D.: "Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. L Efficacy results". Am. J. Obstet. Gynecol., 1992, 167, 1367.

[14] W heeler J. M., Knittle J. D., Miller J. D.: "Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group". Am. J. Obstet. Gynecol., 1993, 169, 26.

[15] Crosignani P. G., Gastaldi A., Lombardi P. L., Montemagno U., Vignali M., Serra G. B., et al.: "Leuprorelin acetate depot vs danazol in the treatment of endometriosis: results of an open mu!ticentre trial". Clin. Ther., 1992, 14 suppl. A, 29.

[16] Shaw R. W.: "An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis". Fertil. Steril., 1992, 58, 265.

[17]'The Nafarelin European Endometriosis Trial Group. Nafarelin for endometriosis: a large scale, danazol-controlled trial of et'ficacy and safety, with 1-year follow-up". Fertil. Steril., 1992, 57, 514.

[18] Henzl M. R., Gordon S. L, Moghissi K., Buttram V. C. Jr., Bergquist C., Jacobson J.: "Administration of nasal nafarelin as compared with oral danazol for endometriosis". N. Eng. J. Med., 1988, 318, 485.

[19] “The American Pert山ty Society. Revised American Fertility Society classification of endometriosis: 1985". Fertil. Steril., 1985, 43, 51.

[20] Barbieri R. L., Evans S., Kistner R. W.: "Danazol in the treatment of endometriosis: analysis of I 00 cases with a 4-year follow-up". Fertil. Steril., 1982, 37, 737.

[21] Barlow D. H.: "Nafarelin in the treatment of infertility caused by endometriosis". Am. J. Obstet. Gynecol., 1990, 162, 576.

[22] Wardle P. G., Mitchell J. D., McLaughlin E. A., Ray B. D., McDermott A., Hull M. G.: "Endometriosis and ovulatory disorder: reduced fertilization in vitro compared with tubal and unexplained infertility". Lancet, 1985, 2, 236.